Cholangiocarcinoma is a rare form of bile duct cancer which affects upwards of 1,000 Brits every year, and can display an usual symptom ...

"People come in with a lump. Sometimes it can be something benign, like a cyst, but it can also be a cancer." Not all warning signs are obvious, however. "It's not just about feeling a lump," Saphier ...

Medically reviewed by Jay N. Yepuri, MDMedically reviewed by Jay N. Yepuri, MD Bile duct cancer, also known as ...

Age, sex, diet, and more can play a role in gallstones and other gallbladder diseases. Learn more about the risk factors.

Due to its rarity, male breast cancer is often diagnosed at a later stage, which can make treatment more challenging. In this article, we share a list of causes, signs and prevention tips for male ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the main goal in a confirmatory trial.

In May, Gilead Sciences announced topline results from the confirmatory Phase 3 TROPiCS-04 study in locally advanced or metastatic urothelial cancer (mUC). The TROPiCS-04 study evaluated Trodelvy ...

The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for bladder cancer in 2021, failed its confirmatory trial earlier this year. Gilead ...

With its lead candidate in a phase 3 trial for a rare eye cancer, Aura Biosciences is looking to expand the drug into a more common disease: bladder cancer. In a phase 1 trial in patients with non ...